OrthoPediatrics announced the launch of a new division, focused on non-surgical intervention for pediatric orthopedics. The OrthoPediatrics Specialty Bracing division will serve as a flagship house of brands and innovative products that expand the Company’s Total Addressable Market by approximately $600 million. Additionally, the Company announced the release of the DF2 Brace as part of its expansion in the non-surgical business for treating kids with musculoskeletal injuries. . OrthoPediatrics’ President of Trauma & Deformity Correction, Joe Hauser will also lead the new non-operative business, commenting, “We are excited for the launch of the new OPSB division, and our continued expansion into pediatric orthopedic non-surgical treatments for kids. This new addition advances our growth strategy of providing a broad product portfolio uniquely designed to treat children while surrounding pediatric orthopedic surgeons with the most comprehensive product offering in the market.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on KIDS:
- OrthoPediatrics Corp. Announces Launch of Specialty Bracing Division
- OrthoPediatrics Corp. to Host Educational and Networking Events at 19th Annual International Pediatric Orthopaedic Symposium (IPOS)
- OrthoPediatrics backs FY23 revenue view $148M-$151M, consensus $149.17M
- OrthoPediatrics reports Q3 adjusted EPS (13c), consensus (22c)
- OrthoPediatrics Corp. Reports Third Quarter 2023 Financial Results